Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market

1. Executive Summary
1.1. Global Market Snapshot
1.2. Key Success Factors
1.3. Strategic Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Definitions
3. Research Methodology
3.1. Preliminary Investigation & Research Design
3.2. Secondary Research & Primary Research
3.3. Data Analysis & Econometric Modelling
3.4. Expert Data Validation
4. Key Emerging Trends Analysis
4.1. Supply-Side Trends
4.2. Demand-Side Trends
5. Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market Value (US$ Mn) and Volume (Tons) Analysis
5.1. Global Market Value (US$ Mn) Analysis, 2017 – 2032
5.2. Incremental $ Opportunity Index, 2022-2032
5.3. Global Market Volume (Tons) Analysis, 2017 – 2032
6. Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market Pricing Analysis
6.1. Regional Level Pricing Analysis and Forecast
6.1.1. Manufacturers Level Pricing
6.1.2. Distributor Level Pricing
6.2. Global Pricing Analysis Benchmark
6.3. Cost Breakdown Analysis
7. Cross-Sectional Analysis
7.1. Cross Analysis of Formulation Type W.R.T. Product Type
8. Supply Vs. Demand Analysis
8.1. Regional Supply Vs. Demand Gap Assessment
8.2. Top Producing Countries Analysis
9. Market Background
9.1. Macroeconomic Factors
9.2. Forecast Factors
9.3. Market Dynamics
9.3.1. Driver
9.3.2. Restraint
9.3.3. Opportunity
9.4. Supply Chain Analysis
9.4.1. List Raw Material Suppliers
9.4.2. List of Manufacturers
9.4.3. List of Distributors
9.4.4. List of End-Users
9.4.5. End-Users Consumption Analysis
9.4.6. Average Profitability Margin Analysis
9.5. Covid-19 Impact Assessment
9.5.1. Economy/Cluster Projections
9.5.2. Covid-19 Economic Assessment
9.5.3. Impact on Target Market
9.5.4. Recovery Scenario
9.6. Regulatory Framework
9.6.1. Regulations of Key Countries
9.6.2. Potential Impact of Regulations
9.7. Porter’s Five Forces Analysis
9.8. Technology Landscape
10. Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market 2017 – 2032 By Product Type
10.1. Introduction
10.2. Key Market Trends
10.3. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Product Type [Value (US$ Mn) and Volume (Tons) Analysis]
10.3.1. 2′-Fucosyllactose (2′-FL)
10.3.2. Lacto-N-neotetraose (LNnT)
10.3.3. 3′-Sialyllactose (3′-SL)
10.3.4. 6′-Sialyllactose (6′-SL)
10.3.5. Others
10.4. Market Attractiveness Analysis by Product Type
11. Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market 2017 – 2032 by Formulation Type
11.1. Introduction
11.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Formulation Type [Value (US$ Mn) and Volume (Tons) Analysis]
11.2.1. Powdered Formula
11.2.2. Liquid Formula
11.3. Market Attractiveness Analysis by Formulation Type
12. Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market 2017 – 2032 by Application
12.1. Introduction
12.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Application [Value (US$ Mn) and Volume (Tons) Analysis]
12.2.1. Infant Formula
12.2.2. Follow-on Formula
12.2.3. Specialty Formula
12.3. Market Attractiveness Analysis by Application
13. Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market 2017 – 2032 by Distribution Channel
13.1. Introduction
13.2. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Distribution Channel[Value (US$ Mn) and Volume (Tons) Analysis]
13.2.1. Pharmacies
13.2.2. Supermarkets and Hypermarkets
13.2.3. Online Retail
13.2.4. Others
13.3. Market Attractiveness Analysis by Distribution Channel
14. Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market Historical Analysis 2017 – 2021 and Forecast 2017 – 2032 by Region
14.1. Introduction
14.2. Key Market Trends
14.3. Historical and Current Market (2017-2021) and Future Market Analysis (2022-2032) By Region [Value (US$ Mn) and Volume (Tons) Analysis]
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. Asia-Pacific
14.3.5. Middle East
14.3.6. Africa
14.4. Market Attractiveness Analysis by Region
15. North America Human Milk Oligosaccharides (HMOs) in Infant Formula Market Historical Analysis 2017 – 2021 and Forecast 2022-2033
15.1. Introduction
15.2. Key Market Trends
15.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By Product Type
15.3.3. By Formulation Type
15.3.4. By Application
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By Formulation Type
15.4.4. By Application
15.4.5. By Distribution Channel
16. Latin America Human Milk Oligosaccharides (HMOs) in Infant Formula Market Historical Analysis 2017 – 2021 and Forecast 2017 – 2032
16.1. Introduction
16.2. Key Market Trends
16.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Rest of Latin America
16.3.2. By Product Type
16.3.3. By Formulation Type
16.3.4. By Application
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Formulation Type
16.4.4. By Application
16.4.5. By Distribution Channel
17. Europe Human Milk Oligosaccharides (HMOs) in Infant Formula Market Historical Analysis 2017 – 2021 and Forecast 2017 – 2032
17.1. Introduction
17.2. Key Market Trends
17.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. UK
17.3.1.5. Spain
17.3.1.6. Netherlands
17.3.1.7. Norway
17.3.1.8. Russia
17.3.1.9. Rest of Europe
17.3.2. By Product Type
17.3.3. By Formulation Type
17.3.4. By Application
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Formulation Type
17.4.4. By Application
17.4.5. By Distribution Channel
17.4.6. By Product Type
17.4.7. By Formulation Type
18. Asia-Pacific Human Milk Oligosaccharides (HMOs) in Infant Formula Market Historical Analysis 2017 – 2021 and Forecast 2017 – 2032
18.1. Introduction
18.2. Key Market Trends
18.3. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.1.4. India
18.3.1.5. Indonesia
18.3.1.6. Thailand
18.3.1.7. Vietnam
18.3.1.8. Australia & New Zealand
18.3.1.9. Rest of Asia-Pacific
18.3.2. By Product Type
18.3.3. By Formulation Type
18.3.4. By Application
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product Type
18.4.3. By Formulation Type
18.4.4. By Application
18.4.5. By Distribution Channel
19. Middle East Human Milk Oligosaccharides (HMOs) in Infant Formula Market Historical Analysis 2017 – 2021 and Forecast 2017 – 2032
19.1. Introduction
19.2. Key Market Trends
19.3. Pricing Analysis
19.4. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
19.4.1. By Country
19.4.1.1. Saudi Arabia
19.4.1.2. Turkey
19.4.1.3. U.A.E.
19.4.1.4. Rest of the Middle East
19.4.2. By Product Type
19.4.3. By Formulation Type
19.4.4. By Application
19.4.5. By Distribution Channel
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product Type
19.5.3. By Formulation Type
19.5.4. By Application
19.5.5. By Distribution Channel
20. Africa Human Milk Oligosaccharides (HMOs) in Infant Formula Market Historical Analysis 2017 – 2021 and Forecast 2017 – 2032
20.1. Introduction
20.2. Key Market Trends
20.3. Pricing Analysis
20.4. Historical and Current Market Size (2017-2021) and Future Market Size Analysis (2022-2032) [Value (US$ Mn) and Volume (Tons) Analysis]
20.4.1. By Country
20.4.1.1. South Africa
20.4.1.2. Nigeria
20.4.1.3. Egypt
20.4.1.4. Rest of Africa
20.4.2. By Product Type
20.4.3. By Formulation Type
20.4.4. By Application
20.4.5. By Distribution Channel
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product Type
20.5.3. By Formulation Type
20.5.4. By Application
20.5.5. By Distribution Channel
21. Competition Analysis
21.1. Tier Structure Breakdown
21.2. Market Share Analysis
21.3. Production Capacity Analysis
21.4. Company Footprint Analysis
21.4.1. Product Footprint of Players
21.4.2. Regional Footprint of Players
21.4.3. Channel Footprint of Players
21.5. Brand Preference Analysis
21.6. Competition Dashboard
22. Company Profiles
22.1. Nestlé S.A.
22.1.1. Company Overview
22.1.2. Product & Financial Portfolio
22.1.3. Manufacturing Facilities
22.1.4. Recent Developments
22.1.5. SWOT Analysis
22.1.6. Strategy Overview
22.2. Abbott Laboratories
22.3. Danone S.A.
22.4. Mead Johnson Nutrition Company
22.5. Arla Foods Ingredients Group P/S
22.6. FrieslandCampina
22.7. Yakult Honsha Co., Ltd.
22.8. Biostime International Holdings Limited
22.9. The Hain Celestial Group, Inc.
22.10. Heinz Baby Corp.
22.11. Chobani LLC
22.12. Meiji Co., Ltd.
22.13. Perrigo Nutritionals
22.14. Westland Co-operative Dairy Company Limited
22.15. Aptaclub
22.16. BioGaia AB
22.17. Holle Baby Food AG
22.18. Parent’s Choice
22.19. PremiMilk
22.20. Bimbosan AG
22.21. Breastmilk Foundation
22.22. Healthy Times
22.23. Hero Group
22.24. HiPP GmbH & Co. Vertrieb KG
22.25. Little Moppet Foods.
23. Assumptions and Acronyms